Filer Snapshot

Wei Zheng SEC EDGAR Filings

SEC filings, ownership reports, and insider transactions for CIK 0001913491.

Entity Type

Individual

Total Filings

8

Latest Filing

17 Feb 2026

Industry

n/a

Save or continue research

Save this filer for return loops, then jump into the latest filing evidence.

Save this research page

Create a free account to save this filer and follow future SEC filing updates.

Review latest filings on this page Browse SEC filer directory
Business address
C/O Connect Biopharma Holdings Ltd, Science & Tech Park, East R&D Bldg, 3 Fl, 6 Beijing West Road, Taicang, China, 215400
Top holdings (Schedule 13G)
CNTB

Sponsored

Quick Takeaways

  • Wei Zheng is an SEC filer tracked under CIK 0001913491.
  • 8 filings are listed on this profile.
  • Common form coverage includes SCHEDULE 13G/A, 144, SC 13G/A and more.

What Changed

  • Latest filing: SCHEDULE 13G/A filed on 17 Feb 2026.
  • Report period: not specified in filing header.

Why This Matters

  • You can quote filing dates and form types directly from the SEC record on this page.
  • Use this profile before deeper ownership or insider analysis to confirm filing history context.

Official SEC Source

Official SEC Source

SEC EDGAR submissions for CIK 0001913491.

See Original Filing

Filer Overview

Wei Zheng has filed 8 SEC EDGAR filings since 25 Feb 2022. Common forms include SCHEDULE 13G/A, 144, SC 13G/A, SC 13G.

Latest Filings

Recent SEC filings for Wei Zheng with direct links to document and filing folders.

About this filer

Wei Zheng files with the SEC under CIK 0001913491. This page aggregates EDGAR filings and related ownership activity.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.